Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: PDT, SVY, WOM, CPG, DEI, ESG

On One Year Anniversary, Organon Introduces Global Environmental, Social and Governance (ESG) Strategy and Commitments with Publication of Inaugural ESG Report


Report lays out blueprint for achieving Organon's purpose and business imperatives to help women and girls achieve their promise through better health

KIRKLAND, QC, June 2, 2022 /CNW/ - Organon Canada Inc., an affiliate of Organon (NYSE: OGN), a global women's healthcare company, which employs over 120 people across Canada, today announced the publication of the company inaugural Environmental, Social, and Governance (ESG) Report for 2021. The ESG report introduces the company's ESG platform, known as Her Promise, and details how the company is working to help women and girls achieve the full potential of their promise through better health. The publication of the ESG Report and launch of Her Promise coincides with Organon's one year anniversary and reflects the company's vision to create a better and healthier every day for every woman in Canada and around the world, and to address disparities by broadening access to treatments to the underserved. The ESG Report was developed by Organon, Organon Canada Inc.'s parent company, to disclose the company's priorities and areas of focus.

As the only global women's healthcare company of its kind, Organon is well positioned to help address several current and growing women's health challenges. For example, nearly half of all pregnancies worldwide ? about 121 million in total ? are unintended, including in Canada. According to a 2019 study, an estimated 218 million women and girls (ages 15-49) in low-and-middle income countries had an unmet need for modern contraception. In Canada, almost half of all pregnancies are unplanned.i Through Her Promise, Organon is making focused investments and forming strategic partnerships with the goal of introducing and expanding access to health solutions to help improve women's health and advance gender equity, inside and outside Organon.  Recently in Québec, Organon Canada worked with the Quebec Ministry of Health and Social Services towards giving women in the province access to more hormonal therapy options to treat symptoms from menopause. This was a result of women expressing their unmet medical needs earlier in the year in that sphere of their life and the company listening to be part of a solution.

"In just one year, Organon has made considerable progress in addressing gender-related disparities in health by listening to women and investing in areas where high unmet needs exist. Since our launch, we have focused on treatment gaps that need to be addressed, like unintended pregnancy, fertility and more, and will continue to strive to deliver innovation, improve access and expand choice for treatments areas that uniquely or disproportionately affect women," says Kevin Ali, Organon's Chief Executive Officer. "The goals stated in our first ESG Report create a roadmap for the future of how we will continue to propel forward and partner to transform the current women's health environment."

"Organon Canada will achieve its purpose by supporting women's whole being, in addition to their reproductive health, and through the delivery of medicines, like biosimilars that treat diseases that impact women disproportionally," says Michael Casia, President and Managing Director, Organon Canada. "Women present with and experience diseases differently than men, and we are committed to helping address their unmet medical needs today and into the future."

On its one-year anniversary, Organon is making the following goals to achieve Her Promise:

In addition, as part of its commitment to advancing gender equity through Her Promise, Organon has provided US $1.4M to Women Deliver to fund its Young Leaders Program and other advocacy work, as well as support the Women Deliver 2023 Conference (WD2023). The funding will help Young Leaders across the world to achieve their advocacy goals in gender equality and health through financial resources, mentorship, and technical assistance.

"The Board is committed to achieving both Organon's business goals as well as contributing to societal goals, and to continuing to drive the company's ESG strategy," says Carrie Cox, Board Chairman. "We are pleased to be in a position to publish a comprehensive ESG report just one year after the company's establishment and highlight our purpose and goals in improving the health of women and girls.

The Board's governance committee, called the ESG Committee, is comprised of five members and chaired by pharmaceutical industry veteran Robert Essner, all whom bring considerable expertise from across a variety of disciplines.

For more details on Organon's ESG strategy, priorities, and initiatives, download the full 2021 ESG Report here.

About Organon

Organon is a global healthcare company with a focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women's health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon's products produce strong cash flows that will support investments in innovation and future growth opportunities in women's health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,300 employees with headquarters located in Jersey City, New Jersey.

For more information, connect with us on LinkedIn and Twitter.

__________________________

i SOGC, Unintended pregnancy ? Pregnancy Info, Accessed May 2022

 

SOURCE Organon Canada Inc.


These press releases may also interest you

1 oct 2022
Consolidated Edison, Inc. ("Con Edison") today announced that it entered into a purchase and sale agreement pursuant to which Con Edison agreed to sell its interest in its wholly-owned subsidiary, Con Edison Clean Energy Businesses, Inc. and its...

1 oct 2022
CGN Europe Energy ("CGN"), a European leader in green energies, is co-organizing the open day of its wind farms located in the south of the city with Town Hall of Assac. Themed "From Wind Farms to Windmills", the 6 kilometers hike is also the first...

1 oct 2022
The most sustainable coffee pod now encapsules the most sustainable coffee. Smile Coffee Werks® upgraded its coffee beans to Fair Trade and USDA Organic ? an astounding compliment to its plant-based, Carbon Neutral, and USDA Biobased pods that are...

30 sep 2022
AIDS Healthcare Foundation (AHF), the largest, non-profit global AIDS organization, in partnership with Broward House is pleased to announce that on Saturday, October 1st, 2022, the opening of a new site for its Food For Health Program in the city of...

30 sep 2022
The MolinaCares Accord ("MolinaCares"), in collaboration with Molina Healthcare of Florida ("Molina"), is donating $300,000 to the Florida Disaster Fund, Farm Share, Harry Chapin Food Bank, and Latino Leadership in the aftermath of Hurricane Ian's...

30 sep 2022
Azure Printed Homes (Azure), innovators of 3D printing building technology of recycled plastic, has been selected by Re-Inhabit, a Southern California home builder, for the production of ten 3D printed homes. Re-Inhabit plans to initially install...



News published on 2 june 2022 at 07:31 and distributed by: